ArticleLeukemia2023

Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.

Larisa Fechina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.